To sum up, the combination of HDAC inhibition and EGFR degradation by GM‐protac could both induce cell apoptosis and cell cycle arrest at phase G1 in osimertinib resistant lung cancer cells. This evidence concerns the gene HDAC9 and lung carcinoma.